Meet The Professors: Myelodysplastic Syndromes Edition, 2016

Individual audio segments:

Track 1:	Prognostic scoring systems in MDS
Track 2:	Use of erythropoiesis-stimulating agents and G-CSF in MD
Track 3:	Iron chelation therapy in MDS managemen
Track 4:	Choice of hypomethylating agent in MDS
Track 5:	Five- versus 7-day therapy with azacitidine
Track 6:	Selection of patients who will benefit from lenalidomide
Track 7:	Clinical trials of checkpoint inhibitors in MDS

Track 8:	Case discussion: An 88-year-old man with high-risk MDS (Dr Brenner)
Track 9:	Case discussion: A 58-year-old woman who is a Jehovah's Witness with a hemoglobin of 4.1 and a bone marrow biopsy consistent with MDS (Dr Rupard)
Track 10:	Case discussion: A 78-year-old man with a hemoglobin of 4 and a bone marrow biopsy compatible with MDS (Dr Morganstein)
Track 11:	Case discussion: A 31-year-old woman with MDS in her first trimester of pregnancy (Dr Rupard)
Track 12:	Case discussion: A 62-year-old man with 20q minus MDS (Dr Brenner)
Track 13:	Case discussion: An 80-year-old woman with MDS and a history of rheumatoid arthritis (Dr Morganstein)